Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Asclepes Research
948
mi
from 98109
Panorama City, CA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Asclepes Research
948
mi
from 98109
Panorama City, CA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
CITrials, Inc. - Riverside & San Bernardino County
980
mi
from 98109
Riverside, CA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
CITrials, Inc. - Riverside & San Bernardino County
980
mi
from 98109
Riverside, CA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
The Hartford Hospital
2429
mi
from 98109
Hartford, CT
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
The Hartford Hospital
2429
mi
from 98109
Hartford, CT
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Childrens National Medical Center
2322
mi
from 98109
Washington,
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Childrens National Medical Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Florida Clinical Research Center, LLC
2545
mi
from 98109
Bradenton, FL
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Florida Clinical Research Center, LLC
2545
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Sarkis Clinical Trials - Parent
2449
mi
from 98109
Gainesville, FL
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Sarkis Clinical Trials - Parent
2449
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
APG Research, LLC
2548
mi
from 98109
Orlando, FL
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
APG Research, LLC
2548
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Medical Research Group of Central Florida
2539
mi
from 98109
Sanford, FL
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Medical Research Group of Central Florida
2539
mi
from 98109
Sanford, FL
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Institute for Behavioral Medicine
2168
mi
from 98109
Smyrna, GA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Institute for Behavioral Medicine
2168
mi
from 98109
Smyrna, GA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Baber Research Group
1709
mi
from 98109
Naperville, IL
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Baber Research Group
1709
mi
from 98109
Naperville, IL
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Lake Charles Clinical Trials LLC
1954
mi
from 98109
Lake Charles, LA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Lake Charles Clinical Trials LLC
1954
mi
from 98109
Lake Charles, LA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Kennedy Krieger Institute
2329
mi
from 98109
Baltimore, MD
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Kennedy Krieger Institute
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Neurobehavioral Medicine Group
1914
mi
from 98109
Bloomfield Hills, MI
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Neurobehavioral Medicine Group
1914
mi
from 98109
Bloomfield Hills, MI
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Jersey Shore University Medical Center
2417
mi
from 98109
Neptune, NJ
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Jersey Shore University Medical Center
2417
mi
from 98109
Neptune, NJ
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Manhattan Behavioral Medicine, LLC
2402
mi
from 98109
New York, NY
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Manhattan Behavioral Medicine, LLC
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Finger Lakes Clinical Research
2164
mi
from 98109
Rochester, NY
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Finger Lakes Clinical Research
2164
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Richmond Behavioral Associates
2399
mi
from 98109
Staten Island, NY
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Richmond Behavioral Associates
2399
mi
from 98109
Staten Island, NY
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
University of Cincinnati Medical Center
1963
mi
from 98109
Cincinnati, OH
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
University of Cincinnati Medical Center
1963
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Research Strategies of Memphis, LLC
1864
mi
from 98109
Memphis, TN
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Research Strategies of Memphis, LLC
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
BioBehavioral Research of Austin
1763
mi
from 98109
Austin, TX
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
BioBehavioral Research of Austin
1763
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Pillar Clinical Research, LLC
1676
mi
from 98109
Dallas, TX
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Pillar Clinical Research, LLC
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
BioBehavioral Research of Austin
1884
mi
from 98109
El Campo, TX
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
BioBehavioral Research of Austin
1884
mi
from 98109
El Campo, TX
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Family Psychiatry of the Woodlands
1866
mi
from 98109
The Woodlands, TX
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Family Psychiatry of the Woodlands
1866
mi
from 98109
The Woodlands, TX
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Aspen Clinical Research, LLC
732
mi
from 98109
Orem, UT
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Aspen Clinical Research, LLC
732
mi
from 98109
Orem, UT
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
University Hospitals at Case Medical Center
2016
mi
from 98109
Cleveland, OH
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
University Hospitals at Case Medical Center
2016
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  1/7/2016
Universitair Ziekenhuis Brussel
4933
mi
from 98109
Bruxelles,
Pediatric Schizophrenia Efficacy and Safety Study
A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 1/7/2016
Universitair Ziekenhuis Brussel
4933
mi
from 98109
Bruxelles,
Click here to add this to my saved trials
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
The Role of Vitamin D and Quetiapine-induced Weight Gain
Status: Enrolling
Updated:  1/7/2016
Alegent Creighton Clinic - Psychiatric Associates (Dodge Street)
1367
mi
from 98109
Omaha, NE
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
The Role of Vitamin D and Quetiapine-induced Weight Gain
Status: Enrolling
Updated: 1/7/2016
Alegent Creighton Clinic - Psychiatric Associates (Dodge Street)
1367
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Psychosis: Early Detection, Intervention and Prevention
Psychosis: Early Detection, Intervention and Prevention
Status: Enrolling
Updated:  1/7/2016
Maine Medical Center
2482
mi
from 98109
Portland, ME
Psychosis: Early Detection, Intervention and Prevention
Psychosis: Early Detection, Intervention and Prevention
Status: Enrolling
Updated: 1/7/2016
Maine Medical Center
2482
mi
from 98109
Portland, ME
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1719
mi
from 98109
Oak Brook, IL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1719
mi
from 98109
Oak Brook, IL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
9
mi
from 98109
Bellevue, WA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
9
mi
from 98109
Bellevue, WA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2244
mi
from 98109
Dothan, AL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2244
mi
from 98109
Dothan, AL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
971
mi
from 98109
Downey, CA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
971
mi
from 98109
Downey, CA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2168
mi
from 98109
Smyrna, GA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2168
mi
from 98109
Smyrna, GA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2110
mi
from 98109
Buffalo, NY
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2458
mi
from 98109
Stony Brook, NY
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2458
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2337
mi
from 98109
Chapel Hill, NC
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1866
mi
from 98109
The Woodlands, TX
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1866
mi
from 98109
The Woodlands, TX
Click here to add this to my saved trials